Prognostic Significance of Tumor–Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
Cells · 26.10.2024 · 13 (21) · 1772
DOI: 10.3390/cells13211772 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cells, online erschienen am 26.10.2024. Verfasst von Ilaria Girolami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, via Lorenz Böh…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The management of head and neck squamous cell carcinoma (HNSCC) relies heavily on TNM staging and WHO histologic grading; however, in recent years, the analysis of prognostic markers expressed in the tumor stroma has gained attention. The tumor–stroma ratio (TSR) quantifies the proportion of tumor tissue relative to the surrounding stromal tissue; it is assessed with the percentage of stromal tissue within the tumor area, with a cutoff point of 50% being widely used to discriminate high-stroma cancer. In this systematic review and meta-analysis, we investigated the potential prognostic role of the TSR in HNSCC. After a literature screening, 24 studies dealing with the TSR and survival outcomes were included. The TSR showed a significant association with overall survival (OS) in both unadjusted and adjusted measures (RR 2.04, CI 1.57–2.65, p < 0.01; HR 2.36 CI 1.89–2.94, p < 0.00001), with an even stronger prognostic potential in oral cavity/oral tongue cancers (RR 2.44 CI 1.84–3.22, p < 0.00001). The TSR also showed prognostic value when dealing with cancer-specific survival and was associated with a reduction in disease-free survival (DFS). In particular, the TSR also retained its prognostic role in terms of DFS when specifically considering early-stage cancers in both unadjusted and adjusted analyses (RR 1.81 CI 1.57–2.10, p < 0.00001; HR 2.09 CI 1.58–2.76, p < 0.00001). Therefore, we conclude that the TSR is a reliable prognostic marker that is easy to assess in routine histological slides and can be effectively implemented in the routine evaluation of HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, via Lorenz Böhler, 5, 39100 Bolzano-Bozen, Italy.
- Department of Otolaryngology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, 39100 Bolzano-Bozen, Italy.
ORCID-Profile: Ilaria Girolami, Monir Abousiam, Esther Hanspeter
Zitieren
APA
Girolami, I., Damiani, D., Negro, R., Abousiam, M., Gazzini, L., Calabrese, L., & Hanspeter, E. (2024). Prognostic Significance of Tumor–Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cells, 13(21), 1772. https://doi.org/10.3390/cells13211772
Vancouver
Girolami I, Damiani D, Negro R, Abousiam M, Gazzini L, Calabrese L, et al. Prognostic Significance of Tumor–Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cells. 2024;13(21):1772. doi:10.3390/cells13211772
BibTeX
@article{Girolami2024,
author = {Girolami, Ilaria and Damiani, Domenico and Negro, Rosa and Abousiam, Monir and Gazzini, Luca and Calabrese, Luca and Hanspeter, Esther},
title = {Prognostic Significance of Tumor–Stroma Ratio (TSR) in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis},
journal = {Cells},
year = {2024},
volume = {13},
number = {21},
pages = {1772},
doi = {10.3390/cells13211772}
}
EUVIMED